Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shock waves vs nerve zaps: which eases heel pain best?

NCT ID NCT06558552

Symptom relief Sponsor: Halil Ibrahim Altun Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compared two noninvasive treatments for chronic heel pain caused by heel spurs: extracorporeal shock wave therapy and a newer nerve stimulation method called transcutaneous pulsed radiofrequency. 100 adults aged 18-65 with heel spurs took part. The goal was to see which treatment better reduces pain and improves foot function.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
transcutaneous pulsed radiofrequency and extracorporeal shock wave therapy
What this could lead to
If successful, this could point toward a noninvasive, drug-free option for easing chronic heel pain from heel spurs.
What could go wrong
This is a small, completed trial with no phase designation, so results may not apply broadly. Both treatments are noninvasive but may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

100 people

The number who actually took part.

Started

Sep 2024

Finished

Apr 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18-65, * Patients diagnosed with calcaneus spur and epin calcaneus in radiological imaging with anamnesis, clinical and physical examination * Patients who signed the voluntary consent form Exclusion Criteria: * Patients who have undergone interventional procedures for heel spurs in the last 6 months, * Morbidly obese patients (BMI\>35 kg/m2), * Patients with advanced decompensated heart failure and pacemakers, * Patients with known transcutaneous pad allergy, patients with skin infection in the area where ESWT was performed or pads were attached, * Patients with metal implants, * Patients with circulatory disorders and lesions, * Patients who cannot communicate and cannot be positioned, * Patients with bleeding disorders, patients with severe psychosis and progressive neurological deficits and muscle diseases, * and pregnant women.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heel spur are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome heel spur

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pain, chronic

Contacts and locations

Locations

  • Kanuni Sultan Süleyman Training and Research Hospital

    Istanbul, 34000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.